US Stock MarketDetailed Quotes

WCGC WCG Clinical

Watchlist
  • 0.000
  • 0.0000.00%
Close May 31 09:30 ET
0Market Cap0.00P/E (TTM)

WCG Clinical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2,406.30%16.32M
102.31%124.2M
651K
61.39M
Net income from continuing operations
31.46%-20.62M
-623.68%-95.27M
---30.09M
--18.19M
Operating gains losses
--525K
172,200.00%5.17M
----
--3K
Depreciation and amortization
4.16%53.04M
218.41%205.7M
--50.92M
--64.6M
Deferred tax
--0
-67.00%-25.19M
---3.67M
---15.08M
Other non cash items
111.27%9.26M
70.22%16.85M
--4.38M
--9.9M
Change In working capital
-33.87%-28M
171.05%12.24M
---20.91M
---17.23M
-Change in receivables
-25.80%-11.23M
-45.09%-19.67M
---8.92M
---13.56M
-Change in prepaid assets
-181.07%-2.14M
474.62%9M
--2.64M
---2.4M
-Change in payables and accrued expense
65.32%-1.16M
195.00%28.05M
---3.36M
--9.51M
-Change in other current liabilities
-116.97%-3.64M
---6.43M
---1.68M
--0
-Change in other working capital
-2.34%-9.82M
111.93%1.29M
---9.6M
---10.78M
Cash from discontinued investing activities
Operating cash flow
2,406.30%16.32M
102.31%124.2M
--651K
--61.39M
Investing cash flow
Cash flow from continuing investing activities
99.49%-14.88M
-2,899.74%-3.06B
-2.91B
-101.86M
Net PPE purchase and sale
-93.99%-9.88M
-15.86%-27.28M
---5.09M
---23.54M
Net business purchase and sale
--0
-3,766.52%-3.03B
---2.9B
---78.32M
Net investment purchase and sale
---5M
----
--0
----
Cash from discontinued investing activities
Investing cash flow
99.49%-14.88M
-2,899.74%-3.06B
---2.91B
---101.86M
Financing cash flow
Cash flow from continuing financing activities
-100.15%-4.53M
7,925.21%3.11B
3.1B
38.75M
Net issuance payments of debt
-100.19%-2.68M
2,772.91%1.41B
--1.39B
--49.08M
Net other financing activities
-100.11%-1.86M
16,547.34%1.7B
--1.71B
---10.33M
Cash from discontinued financing activities
Financing cash flow
-100.15%-4.53M
7,925.21%3.11B
--3.1B
--38.75M
Net cash flow
Beginning cash position
--178.1M
--0
--0
--35.13M
Current changes in cash
-101.60%-3.1M
10,411.41%178.08M
--193.47M
---1.73M
Effect of exchange rate changes
-83.33%-11K
-85.82%19K
---6K
--134K
End cash Position
-9.55%174.99M
431.08%178.1M
--193.46M
--33.54M
Free cash flow
244.81%6.43M
156.09%96.93M
---4.44M
--37.85M
Currency Unit
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2,406.30%16.32M102.31%124.2M651K61.39M
Net income from continuing operations 31.46%-20.62M-623.68%-95.27M---30.09M--18.19M
Operating gains losses --525K172,200.00%5.17M------3K
Depreciation and amortization 4.16%53.04M218.41%205.7M--50.92M--64.6M
Deferred tax --0-67.00%-25.19M---3.67M---15.08M
Other non cash items 111.27%9.26M70.22%16.85M--4.38M--9.9M
Change In working capital -33.87%-28M171.05%12.24M---20.91M---17.23M
-Change in receivables -25.80%-11.23M-45.09%-19.67M---8.92M---13.56M
-Change in prepaid assets -181.07%-2.14M474.62%9M--2.64M---2.4M
-Change in payables and accrued expense 65.32%-1.16M195.00%28.05M---3.36M--9.51M
-Change in other current liabilities -116.97%-3.64M---6.43M---1.68M--0
-Change in other working capital -2.34%-9.82M111.93%1.29M---9.6M---10.78M
Cash from discontinued investing activities
Operating cash flow 2,406.30%16.32M102.31%124.2M--651K--61.39M
Investing cash flow
Cash flow from continuing investing activities 99.49%-14.88M-2,899.74%-3.06B-2.91B-101.86M
Net PPE purchase and sale -93.99%-9.88M-15.86%-27.28M---5.09M---23.54M
Net business purchase and sale --0-3,766.52%-3.03B---2.9B---78.32M
Net investment purchase and sale ---5M------0----
Cash from discontinued investing activities
Investing cash flow 99.49%-14.88M-2,899.74%-3.06B---2.91B---101.86M
Financing cash flow
Cash flow from continuing financing activities -100.15%-4.53M7,925.21%3.11B3.1B38.75M
Net issuance payments of debt -100.19%-2.68M2,772.91%1.41B--1.39B--49.08M
Net other financing activities -100.11%-1.86M16,547.34%1.7B--1.71B---10.33M
Cash from discontinued financing activities
Financing cash flow -100.15%-4.53M7,925.21%3.11B--3.1B--38.75M
Net cash flow
Beginning cash position --178.1M--0--0--35.13M
Current changes in cash -101.60%-3.1M10,411.41%178.08M--193.47M---1.73M
Effect of exchange rate changes -83.33%-11K-85.82%19K---6K--134K
End cash Position -9.55%174.99M431.08%178.1M--193.46M--33.54M
Free cash flow 244.81%6.43M156.09%96.93M---4.44M--37.85M
Currency Unit USDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg